CareMax Ebitda from 2010 to 2024

CMAX Stock  USD 0.42  0.15  26.32%   
CareMax EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, CareMax EBITDA regression line of annual values had r-squared of  0.38 and arithmetic mean of (74,338,551). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-590.5 M
Current Value
-560.9 M
Quarterly Volatility
204 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CareMax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareMax's main balance sheet or income statement drivers, such as Interest Expense of 57.2 M, Minority Interest of 66.4 K or Depreciation And Amortization of 41.3 M, as well as many indicators such as Price To Sales Ratio of 0.0704, Dividend Yield of 0.0174 or PTB Ratio of 0.86. CareMax financial statements analysis is a perfect complement when working with CareMax Valuation or Volatility modules.
  
Check out the analysis of CareMax Correlation against competitors.
For more information on how to buy CareMax Stock please use our How to Invest in CareMax guide.

Latest CareMax's Ebitda Growth Pattern

Below is the plot of the Ebitda of CareMax over the last few years. It is CareMax's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CareMax's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

CareMax Ebitda Regression Statistics

Arithmetic Mean(74,338,551)
Geometric Mean16,027,685
Coefficient Of Variation(274.40)
Mean Deviation133,696,766
Median7,541,758
Standard Deviation203,987,927
Sample Variance41611.1T
Range601.6M
R-Value(0.61)
Mean Square Error27922.2T
R-Squared0.38
Significance0.01
Slope(28,002,971)
Total Sum of Squares582555T

CareMax Ebitda History

2024-560.9 M
2023-590.5 M
2022-15.4 M
2021-34.9 M
202011.2 M

About CareMax Financial Statements

CareMax investors use historical fundamental indicators, such as CareMax's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CareMax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-590.5 M-560.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CareMax Stock Analysis

When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.